Key Themes

Science & Research

Innovation & Technology

Governance & Metrics

Transformational Leadership

Culture & Consequences

Community Views

Starling Insights features contributions from some of the top thought leaders from industry and academia.

Amy Edmondson

Professor Edmondson is the Novartis Professor of Leadership and Management at Harvard Business School, a chair established to support study of human interactions that lead to the creation of successful enterprises and the betterment of society. She studies leadership, psychological safety, and organizational learning.

View Profile

Gary Cohn

As Assistant to the President for Economic Policy and Director of the National Economic Council (2017-2018), Gary Cohn managed the US economic policy agenda, stimulating economic expansion, job creation, and wage increases through historic tax and regulatory reform. Prior to that he was the President and Chief Operating Officer at Goldman Sachs where he worked for more than 25 years.

View Profile

Klaas Knot

Klaas Knot is President of De Nederlandsche Bank and is the Chair of the Financial Stability Board. He is also a member of the Governing Council and the General Council of the European Central Bank, member of the European Systemic Risk Board, member of the International Monetary Fund's Board of Governors and a member of the Board of Directors of the Bank for International Settlements.

View Profile

Axel Weber

Axel Weber is the past-Chair of UBS and the past-President of the German Bundesbank and a member of the European Central Bank Governing Council from 2004 to 2011. He is a member of the Group of 30.

View Profile

All Community Views Compendium Contributors

Follow Topic Follow Contributor Share Feedback

Reimagining Ethics, Risks & Compliance with Behavioral Science at Novartis

by Antoine Ferrere

Global Head of Behavioral & Data Science, Novartis

Compendium

It’s fair to say that when we started our journey, in September 2019, there was no established “best practice” — some easy 5-point plans or magic-quadrant-endorsed vendors — to help us in bringing behavioural science to the task of improving and transforming how we drive and embed a more reliably ethical culture, manage behavioural risks, and ensure greater compliance. There still isn’t ... (cont)

This content is for Members and registered Observers only

Members have full access to all articles and related content from past Compendium and Starling's regular updates and reports.

Observers can access a limited number of articles and may purchase articles on an ala carte basis.

Reimagining Ethics, Risks & Compliance with Behavioral Science at Novartis

Join The Discussion

See something that doesn't look quite right?